https://arxiv.universalpublishings.com/id/eprint/65786 2026-05-26T15:55:55Z info:eu-repo/semantics/descriptiveMetadata https://arxiv.universalpublishings.com/id/eprint/65786/ INTEGRATED THERAPEUTIC STRATEGIES AND PERSONALIZED APPROACHES IN THE MANAGEMENT OF LUMINAL B HER2-NEGATIVE BREAST CANCER: A CLINICAL-STATISTICAL ANALYSIS Sevara, Alimbayeva Dilmurod, Axadullayev Akhmadjan, Madaminov Breast cancer (BC) remains a leading cause of female morbidity and mortality globally. Modern management has shifted from a "one-size-fits-all" approach to molecular-subtype-driven personalized therapy. This study evaluates the clinical efficacy of dose-dense neoadjuvant chemotherapy (NACT) combined with targeted hormonal maintenance in patients with Luminal B HER2-negative breast cancer (stages IIA-IIIB). Analyzing a cohort of 84 patients, we assessed the objective response rate (ORR) and the frequency of pathological complete response (pCR). Statistical analysis using Student's t-test and $\chi^2$ criteria demonstrated that the integration of taxane-based dose-dense regimens significantly improves surgical outcomes compared to standard FEC protocols ($p < 0.05$). The findings emphasize the necessity of tailoring systemic therapy based on Ki-67 proliferation indices and lymphovascular invasion markers to optimize long-term survival. Center for Tech and Media Research 2026-02-22 Maqola NonPeerReviewed Sevara, Alimbayeva, Dilmurod, Axadullayev, Akhmadjan, Madaminov (2026) INTEGRATED THERAPEUTIC STRATEGIES AND PERSONALIZED APPROACHES IN THE MANAGEMENT OF LUMINAL B HER2-NEGATIVE BREAST CANCER: A CLINICAL-STATISTICAL ANALYSIS. Multidisciplinary Journal of Science and Technology. https://mjstjournal.com/index.php/mjst/article/view/6884 oai:ojs.pkp.sfu.ca:article/6884 oai:ojs.pkp.sfu.ca:article/6884 info:eu-repo/semantics/humanStartPage